AnaptysBio Inc (ANAB)
US$ 18.44-1.44%
Price Chart
Key Statistics
Market Cap
$ 776.96M
P/E Ratio
0.00
Revenue (TTM)
$ 111.87M
Volume
1.2M
52W High
$ 41.31
52W Low
$ 12.21
Dividend Yield
0.00%
Beta
-0.27
Technicals
50-Day MA
22.1297
200-Day MA
21.2898
52 Week High
41.3083
52 Week Low
12.21
About ANAB
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics.
Employees
136
Headquarters
San Diego, CA
CEO
Mr. Daniel R. Faga
Latest News
AnaptysBio (NASDAQ:ANAB) Stock Price Up 7.6% - Here's Why - MarketBeat
2 days ago • Google News
Insider Sale: Director at $ANAB Sells 7,250 Shares - Quiver Quantitative
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg